Better health is only possible when medications are accessible and affordable. Our annual Express Scripts Drug Trend Report is the industry’s most comprehensive and influential examination of year-ove...
From the beginning, our members have been our focus. On their behalf, we’ve acted first to tackle the toughest challenges in health care, even when we acted alone. And we’re just getting started.
Getting to the Rare Diagnosis: 7.6 Years and 7 Different Doctors
For patients with rare disease, getting to the right diagnosis is just the beginning of their journey. Our Rare Conditions Care Value Program® offers personalized support to help patients manage their...
A Call for A Consensus: Price Increases in Branded Drugs Are Unsustainable
Since 2008, brand medications have risen in price an average 232%. We need to work with pharma and the government for common-sense legislation and regulatory changes.
Health care remains uncoordinated and costly. Consider diabetes, one of the most expensive conditions to manage. Prevalence continues to rise, despite advancements.
Nonadherence Puts Patients With Multiple Sclerosis on a Dangerous Path
Patients diagnosed with multiple sclerosis (MS) face unpredictable and increasingly debilitating symptoms. Nonadherence can make these adverse events more costly and dangerous.
Working with Regeneron and Sanofi, Express Scripts directly delivers drug-specific savings to patients, making PCSK9 therapy more affordable and more accessible.
A Wholehearted Solution: Cardiovascular Care ValueSM
Express Scripts’ new Cardiovascular Care ValueSM program expands on our SafeGuardRx® Cholesterol Care ValueSM program to holistically tackle the clinical and financial...
Express Scripts Leads Industry with New HIV Prevention Program
The HIV Care ValueSM program, part of the company’s SafeGuardRx® platform, will drive value and improve cost predictability for employers, health plans, and people at risk for HIV.
HIV Care Value Program: Prevention and Predictability
Our new industry-first HIV Care ValueSM program, part of the SafeGuardRx® platform, will drive value and improve cost predictability for employers, health plans, and people at risk for HIV.
Health Care Trend: Managing Rising Prescription Drug Costs
Ensuring access and affordability in the face of increasing drug costs and market pressures continues to be a priority for plan sponsors. (Estimated reading time: ~3 mins.)
SafeGuardRx: Delivering Better Health and Affordability
This first-to-market value-based program improves patient engagement and increases medication adherence while reducing costs for some of the costliest therapies.
